Limited Medicare Coverage Policy Proposed For Depression VNS Treatment
The US Centers for Medicare and Medicaid Services' proposed national coverage policy for vagus nerve stimulation for depression would allow coverage only in a randomized controlled trial, stipulating multiple caveats on patient choice and endpoints. Manufacturer LivaNova says it is preparing to launch a qualifying study.
